• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻女性乳腺癌。

Breast cancer in young women.

机构信息

Womens College Research Institute, 790 Bay Street, Toronto, ON M5G 1N8, Canada.

出版信息

Nat Rev Clin Oncol. 2012 Jun 26;9(8):460-70. doi: 10.1038/nrclinonc.2012.102.

DOI:10.1038/nrclinonc.2012.102
PMID:22733233
Abstract

About one in 300 women will be diagnosed with breast cancer before the age of 40. Advances in screening have not had an impact on mortality in women who are too young to be candidates for screening. Risk factors for early breast cancer include a lean body habitus and recent use of an oral contraceptive. Breast cancers in very young women are typically aggressive, in part owing to the over-representation of high-grade, triple-negative tumours, but young age is an independent negative predictor of cancer-specific survival. Very early age-of-onset also correlates strongly with the risk of local recurrence and with the odds of contralateral breast cancer. Given the high risks of local and distant recurrence in young women with invasive breast cancer, most (if not all) young patients are candidates for chemotherapy. It is hoped that by increasing breast cancer awareness, the proportion of invasive breast cancers that are diagnosed at 2.0 cm or smaller will increase and that this will lead to a reduction in mortality.

摘要

大约每 300 名女性中就有 1 人会在 40 岁之前被诊断出患有乳腺癌。虽然筛查技术有所进步,但对于年龄太小而不能进行筛查的女性来说,这并没有对死亡率产生影响。早期乳腺癌的风险因素包括偏瘦的体型和近期使用口服避孕药。非常年轻的女性的乳腺癌通常更具侵袭性,部分原因是高级别、三阴性肿瘤的比例过高,但年轻是癌症特异性生存的独立负预测因素。发病年龄很早与局部复发风险和对侧乳腺癌的几率也密切相关。鉴于年轻女性浸润性乳腺癌局部和远处复发的风险很高,大多数(如果不是全部)年轻患者都适合化疗。人们希望通过提高对乳腺癌的认识,将诊断为 2.0 厘米或更小的浸润性乳腺癌的比例增加,并由此降低死亡率。

相似文献

1
Breast cancer in young women.年轻女性乳腺癌。
Nat Rev Clin Oncol. 2012 Jun 26;9(8):460-70. doi: 10.1038/nrclinonc.2012.102.
2
Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.预防性医疗保健,1999年更新:3. 乳腺癌后的随访。加拿大预防性医疗保健特别工作组。
CMAJ. 1999 Oct 19;161(8):1001-8.
3
Who should not undergo breast conservation?哪些人不适合进行保乳治疗?
Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021.
4
Breast cancer in very young women.年轻女性乳腺癌。
Eur J Surg Oncol. 2011 Dec;37(12):1030-7. doi: 10.1016/j.ejso.2011.08.133. Epub 2011 Sep 21.
5
Predictors of time to death after distant recurrence in breast cancer patients.乳腺癌远处复发后死亡时间的预测因素。
Breast Cancer Res Treat. 2019 Jan;173(2):465-474. doi: 10.1007/s10549-018-5002-9. Epub 2018 Oct 16.
6
[Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].[早期浸润性乳腺癌治疗中的循证放疗:传统临床特征与生物标志物]
Magy Onkol. 2009 Mar;53(1):7-14. doi: 10.1556/MOnkol.53.2009.1.2.
7
Stage 0 to stage III breast cancer in young women.年轻女性的0期至III期乳腺癌
J Am Coll Surg. 2000 May;190(5):523-9. doi: 10.1016/s1072-7515(00)00257-x.
8
Multi-agent chemotherapy for early breast cancer.早期乳腺癌的多药联合化疗
Cochrane Database Syst Rev. 2002(1):CD000487. doi: 10.1002/14651858.CD000487.
9
Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study.40 岁以下早期乳腺癌女性是否应常规进行 21 基因复发评分检测:一项 SEER 数据库研究。
Breast. 2020 Feb;49:233-241. doi: 10.1016/j.breast.2019.12.013. Epub 2019 Dec 26.
10
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.DEAR1是腺泡形态发生的主要调节因子,也是早发性乳腺癌局部无复发生存的独立预测指标。
PLoS Med. 2009 May 26;6(5):e1000068. doi: 10.1371/journal.pmed.1000068. Epub 2009 May 5.

引用本文的文献

1
Clinical-pathological patterns and prognosis of young women with breast cancer brain metastases: a single-center retrospective study.年轻女性乳腺癌脑转移的临床病理模式及预后:一项单中心回顾性研究
J Neurooncol. 2025 Sep 9. doi: 10.1007/s11060-025-05212-9.
2
Hospital and community supportive care for young women with breast cancer: a scoping review and environmental scan.针对年轻乳腺癌女性的医院及社区支持性护理:一项范围综述与环境扫描
J Cancer Surviv. 2025 Jul 9. doi: 10.1007/s11764-025-01846-w.
3
Global, Regional, and National Burden of Breast Cancer in Adolescents and Young Adults Aged 15-39 Years From 1990 to 2021 Based on the Global Burden of Disease Study 2021.

本文引用的文献

1
The R337H mutation in TP53 and breast cancer in Brazil.巴西TP53基因中的R337H突变与乳腺癌
Hered Cancer Clin Pract. 2012 Mar 28;10(1):3. doi: 10.1186/1897-4287-10-3.
2
Predictive factors for local recurrence in breast cancer.乳腺癌局部复发的预测因素。
Semin Radiat Oncol. 2012 Apr;22(2):100-7. doi: 10.1016/j.semradonc.2011.12.001.
3
The relationship of mammographic density and age: implications for breast cancer screening.乳腺密度与年龄的关系:对乳腺癌筛查的影响。
基于《2021年全球疾病负担研究》的1990年至2021年15至39岁青少年和青年乳腺癌的全球、区域和国家负担
Cancer Innov. 2025 Jun 6;4(4):e70016. doi: 10.1002/cai2.70016. eCollection 2025 Aug.
4
Evaluating PREDICT and developing outcome prediction models in early-onset breast cancer using data from Alberta, Canada.利用加拿大艾伯塔省的数据评估PREDICT并开发早期乳腺癌的预后预测模型。
Breast Cancer Res Treat. 2025 Jun;211(2):399-408. doi: 10.1007/s10549-025-07654-1. Epub 2025 Mar 12.
5
MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer.MGAT4EP促进肿瘤进展,并作为乳腺癌的一个预后标志物。
Cancer Biol Ther. 2025 Dec;26(1):2475604. doi: 10.1080/15384047.2025.2475604. Epub 2025 Mar 11.
6
Sociodemographic characteristics and health status of women with breast cancer and COVID 19 diagnosis by menopausal status a cross sectional study.按绝经状态划分的乳腺癌合并新冠病毒肺炎诊断女性的社会人口学特征和健康状况:一项横断面研究
Sci Rep. 2025 Jan 21;15(1):2648. doi: 10.1038/s41598-025-86710-8.
7
Pathway to care among adolescents and young adults with breast cancer in Nigeria: a mixed methods study.尼日利亚青少年和青年乳腺癌患者的就医途径:一项混合方法研究。
BMC Cancer. 2025 Jan 6;25(1):11. doi: 10.1186/s12885-024-13420-1.
8
Novel models by machine learning to predict the risk of cardiac disease-specific death in young patients with breast cancer.用于预测年轻乳腺癌患者特定心脏病死亡风险的机器学习新模型。
Discov Oncol. 2024 Dec 18;15(1):809. doi: 10.1007/s12672-024-01676-9.
9
Analysis the Burden of Breast Cancer Among Adolescents and Young Adults Using the Global Burden of Disease 2021.利用《2021年全球疾病负担》分析青少年和青年成人中的乳腺癌负担。
Ann Surg Oncol. 2025 Mar;32(3):2056-2069. doi: 10.1245/s10434-024-16648-0. Epub 2024 Dec 12.
10
Tumour biology and survival outcomes in young women with breast cancer: single-centre retrospective analysis.年轻乳腺癌女性的肿瘤生物学与生存结局:单中心回顾性分析
BJS Open. 2024 Oct 29;8(6). doi: 10.1093/bjsopen/zrae138.
AJR Am J Roentgenol. 2012 Mar;198(3):W292-5. doi: 10.2214/AJR.10.6049.
4
A model for breast cancer risk based on stem-cell theory.基于干细胞理论的乳腺癌风险模型。
Curr Oncol. 2012 Feb;19(1):9-11. doi: 10.3747/co.19.1003.
5
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.利用基因表达谱阐明年轻女性乳腺癌的预后和生物学特性。
Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599. Epub 2012 Jan 18.
6
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.不同化疗方案治疗早期乳腺癌的比较:123 项随机试验 10 万名女性长期结局的荟萃分析。
Lancet. 2012 Feb 4;379(9814):432-44. doi: 10.1016/S0140-6736(11)61625-5. Epub 2011 Dec 5.
7
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.在一个大型的年轻女性乳腺癌患者队列中,根据患者年龄的不同,其病理特征和分子表型也不同。
Breast Cancer Res Treat. 2012 Feb;131(3):1061-6. doi: 10.1007/s10549-011-1872-9. Epub 2011 Nov 13.
8
Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.系统分析乳腺癌形态学揭示了与生存相关的基质特征。
Sci Transl Med. 2011 Nov 9;3(108):108ra113. doi: 10.1126/scitranslmed.3002564.
9
Adjuvant therapies for very young women with early stage breast cancer.早期乳腺癌的非常年轻女性的辅助治疗。
Breast. 2011 Oct;20 Suppl 3:S146-9. doi: 10.1016/S0960-9776(11)70313-7.
10
Adverse health outcomes in women exposed in utero to diethylstilbestrol.子宫内暴露于己烯雌酚的女性的不良健康后果。
N Engl J Med. 2011 Oct 6;365(14):1304-14. doi: 10.1056/NEJMoa1013961.